Your browser doesn't support javascript.
loading
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial.
Hull, Thomas D; Malgaroli, Matteo; Gazzaley, Adam; Akiki, Teddy J; Madan, Alok; Vando, Leonardo; Arden, Kristin; Swain, Jack; Klotz, Madeline; Paleos, Casey.
Afiliação
  • Hull TD; Institute for Psycholinguistics and Digital Health, United States of America. Electronic address: tdh732@mail.harvard.edu.
  • Malgaroli M; Department of Psychiatry, NYU Grossman School of Medicine, United States of America.
  • Gazzaley A; University of California, San Francisco, United States of America.
  • Akiki TJ; Center for Behavioral Health, Neurological Institute, Cleveland Clinic, United States of America.
  • Madan A; Houston Methodist Behavioral Health, United States of America.
  • Vando L; Mindbloom, United States of America.
  • Arden K; Mindbloom, United States of America.
  • Swain J; Mindbloom, United States of America.
  • Klotz M; Mindbloom, United States of America.
  • Paleos C; Mindbloom, United States of America.
J Affect Disord ; 314: 59-67, 2022 10 01.
Article em En | MEDLINE | ID: mdl-35809678
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / COVID-19 / Ketamina Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Telemedicina / COVID-19 / Ketamina Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article